Comparison of selective agonists at cannabinoid CB1 and CB2 receptors on agonistic behaviour in mice

被引：0
|
作者：
Sulcova, A [1 ]
机构：
[1] Masaryk Univ, Fac Med, Dept Pharmacol, CS-66243 Brno, Czech Republic
来源：
BEHAVIOURAL PHARMACOLOGY | 2002年 / 13卷 / 5-6期
关键词：
D O I：
暂无
中图分类号：
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号：
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要：
引用
收藏
页码：505 / 505
页数：1
相关论文
共 50 条
  • [31] Imaging Cannabinoid Receptors: A Brief Collection of Covalent and Fluorescent Probes for CB1 and CB2 Receptors
    Hamilton, Alexander J.
    Payne, Alan D.
    Mocerino, Mauro
    Gunosewoyo, Hendra
    AUSTRALIAN JOURNAL OF CHEMISTRY, 2021, 74 (06) : 416 - 432
  • [32] Cross-regulation of cannabinoid CB1 and CB2 receptors governs hepatic steatosis
    Yang, Ying-Ying
    Lin, Han-Chieh
    LIVER INTERNATIONAL, 2010, 30 (10) : 1397 - 1399
  • [33] Characterization of structural requirements for ligand binding to the CB1 and CB2 cannabinoid receptors.
    Berglund, BA
    Fleming, PR
    Rice, K
    Howlett, AC
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R726 - R726
  • [34] Opposing roles of CB1 and CB2 cannabinoid receptors in the stimulant and rewarding effects of cocaine
    Gobira, Pedro H.
    Oliveira, Ana C.
    Gomes, Julia S.
    da Silveira, Vivian T.
    Asth, Laila
    Bastos, Juliana R.
    Batista, Edleusa M.
    Issy, Ana C.
    Okine, Bright N.
    de Oliveira, Antonio C.
    Ribeiro, Fabiola M.
    Del Bel, Elaine A.
    Aguiar, Daniele C.
    Finn, David P.
    Moreira, Fabricio A.
    BRITISH JOURNAL OF PHARMACOLOGY, 2019, 176 (10) : 1541 - 1551
  • [35] Cannabinoid CB2 Agonist GW405833 Suppresses Inflammatory and Neuropathic Pain through a CB1 Mechanism that is Independent of CB2 Receptors in Mice
    Li, Ai-Ling
    Carey, Lawrence M.
    Mackie, Ken
    Hohmann, Andrea G.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2017, 362 (02): : 296 - 305
  • [36] DISTINCT ROLES OF CB1 AND CB2 CANNABINOID RECEPTORS IN HUMAN BRONCHIAL EPITHELIAL CELLS
    Elzinga, C. R. S.
    Roscioni, S. S.
    Gkoumassi, E.
    Van der Horn, H. J.
    Warnders, F. J.
    Van Streun, E. L. P.
    Nelemans, S. A.
    Meurs, H.
    Zaagsma, J.
    Schmidt, M.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 379 (02) : 202 - 202
  • [37] Expression of cannabinoid receptors CB1 and CB2 in canine cutaneous mast cell tumours
    Rinaldi, Valentina
    Boari, Andrea
    Ressel, Lorenzo
    Bongiovanni, Laura
    Crisi, Paolo Emidio
    Cabibbo, Emanuele
    Finotello, Riccardo
    RESEARCH IN VETERINARY SCIENCE, 2022, 152 : 530 - 536
  • [38] Control of spasticity in a multiple sclerosis model is mediated by CB1, not CB2, cannabinoid receptors
    Pryce, G.
    Baker, D.
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 150 (04) : 519 - 525
  • [39] Allosteric modulators targeting cannabinoid cb1 and cb2 receptors: implications for drug discovery
    Gado, Francesca
    Meini, Serena
    Bertini, Simone
    Digiacomo, Maria
    Macchia, Marco
    Manera, Clementina
    FUTURE MEDICINAL CHEMISTRY, 2019, 11 (15) : 2019 - 2037
  • [40] Dissecting the role of CB1 and CB2 receptors in cannabinoid reward versus aversion using transgenic CB1- and CB2-knockout mice
    Li, Xia
    Hempel, Briana J.
    Yang, Hong-Ju
    Han, Xiao
    Bi, Guo-Hua
    Gardner, Eliot L.
    Xi, Zheng-Xiong
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 43 : 38 - 51
12345